<DOC>
	<DOCNO>NCT02561533</DOCNO>
	<brief_summary>Immunohistochemical detection BRAF-V600E mutation pre-operative fine needle aspiration biopsy ( FNAB ) patient suspect papillary thyroid carcinoma , use mutation specific antibody VE1 .</brief_summary>
	<brief_title>Detection BRAF Mutation FNAB From Papillary Thyroid Carcinoma</brief_title>
	<detailed_description>The BRAF mutation report present approximately 50 % papillary thyroid carcinoma ( PTC ) . The mutation associate poor prognosis advance disease stage . Therefore , pre-operative detection BRAF-V600E mutation may clinical interest order individualize treatment patient BRAF positive PTC . FNABs perform immediately thyroid operation , BRAF-V600E detection use VE1 perform clot . The VE1 stain compare mutation status remove cancer control tissue use Cobas test .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>Bethesda system report thyroid cytology ( BSRTC ) group 56 preoperative FNAB nodule ( &gt; 1cm ) Undergoing thyroid surgery ( histology index nodule ) Not undergo thyroid surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>